TARGETING ADAPTIVE PATHWAYS IN ABIRATERONE- AND ENZALUTAMIDE- REFRACTORY INTERMEDIATE ATYPICAL CARCINOMA
$833,819FY2016Department of the ArmyDOD
Regents Of The University Of California, San Francisco, The
Regents Of The University Of California, San Francisco, The